Thursday, October 25, 2012

When I get to the bottom I go back to the top of the pile

Big pharma approaching bottom of patent cliff

Pharma companies had a bleak day today, with three of the industry’s biggest players reporting falling sales as their best-selling products continue to fall off the ‘patent cliff’. There are signs, though, that the slide may be bottoming out for some.

Worst hit was AstraZeneca, which reported a 15% drop in revenue in the third quarter of the year and a 50% drop in earnings per share, a measure of profitability.

No comments: